Appeal No. 2004-1761 Page 21
Application No. 10/044,807
We note that this application is one of several on appeal that share the same
assignee.3 In each of these cases, regardless of the specific facts of the case, the
appellants have asserted the same DNA chip, gene-mapping, and exon splice junction
arguments. It would therefore appear that Appellants view these potential uses as
utilities that can be asserted for any cDNA they isolate, regardless of how little is known
about it, which (they hope) will nonetheless serve as a basis for patent protection and
secure for Appellants any value that might become apparent in the future, after they or
others have further characterized the claimed products. This is precisely the type of
result that the Brenner Court sought to avoid by requiring disclosure of a substantial
utility to satisfy § 101. See 148 U.S. at 535-36, 148 USPQ at 696: [The Court was not]
“blind to the prospect that what now seems without ‘use’ may tomorrow command the
grateful attention of the public. But a patent is not a hunting license. It is not a reward
for the search, but compensation for its successful conclusion.” Id.
The polynucleotides of the instant claims may indeed prove to be useful (and
valuable), after the in vivo role of the encoded protein is discovered. The work required
to confer value on the claimed products, however, remains to be done. The instant
specification’s disclosure does not justify a grant of patent rights. See Brenner, 383
U.S. at 534, 148 USPQ at 695: “[A] process patent in the chemical field, which has not
been developed and pointed to the degree of specific utility, creates a monopoly of
knowledge which should be granted only if clearly commanded by the statute. Until the
process claim has been reduced to production of a product shown to be useful, the
3 Such applications include 09/460,594 (Appeal No. 2003-1528), 09/804,969 (2003-1794); 09/802,116
(2003-2017); 09/822,807 (2003-2028); and 09/564,557 (2004-0343).
Page: Previous 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Next
Last modified: November 3, 2007